A Randomized Trial of 4% Nebulized Lignocaine vs. 10% Lignocaine Spray in Patients Undergoing Flexible Bronchoscopy
Summary
Flexible bronchoscopy is common procedure used in the diagnosis and treatment of a variety of tracheobronchial diseases. During routine diagnostic flexible bronchoscopy, the most distressing symptom experienced by the patients is a cough, and control of a cough is vital for a successful procedure. The investigators hypothesized that either nebulized lignocaine or lignocaine spray given alone prior to flexible bronchoscopy for inducing topical anesthesia will have similar efficacy compared to the combination of the two agents.
Timeline
- Start
- 2017-05-01
- Primary completion
- 2018-06-30
- Completion
- 2018-06-30
Outcome
Met primary endpoint
paper subject-rated cough severity was significantly lower in group B compared to group C or group A PMID 31299247 ↗
paper Ten actuations of 10% lignocaine oropharyngeal spray were superior to nebulized lignocaine or their combination for topical anesthesia during diagnostic flexible bronchoscopy. PMID 31299247 ↗
Drugs
| Evaluation | Drug | Modality | Dose | Route |
|---|---|---|---|---|
| Subject | Lidocaine | Other / unclassified | 2.5 ml | Inhaled |
| Subject | Lidocaine | Other / unclassified | 4 % | Inhaled |
| Subject | Lidocaine | Other / unclassified | 10 mg | Inhaled |
| Subject | Lidocaine | Other / unclassified | 10 % | Inhaled |
Indications
No indication recorded.